Induction and prevention of experimental arteriovenous fistula infections.

Antimicrobial Agents and Chemotherapy
T W Lane, E Abrutyn

Abstract

Arteriovenous fistulae (AVF) between the femoral vessels were prepared in 20 rabbits to determine if local endovascular infections could be induced and if antibiotic prophylaxis could prevent infection. Twenty-four hours after bacterial challenge with 10(6) Staphylococcus aureus all 20 AVF were culture positive, whereas 19 of the 20 contralateral, unoperated femoral vessels were sterile. Two rabbits with AVF, followed for 30 days after receiving staphylocci, had intermittently positive blood cultures and had positive cultures of the AVF and heart valves at autopsy. Two groups of ten rabbits with AVF received either prophylactic oxacillin or vancomycin 0.5 h before bacterial challenge. Only 2 of 10 animals receiving oxacillin and 1 of 10 receiving vancomycin had positive AVF cultures at 24 h, a significant reduction in the incidence of endovascular infection compared with that in controls (P less than 0.001 by Fisher's exact test). This model, which reliably results in infection, can be used to study the pathophysiology, prevention, and treatment of AVF infections.

References

Aug 1, 1977·The Journal of Infectious Diseases·C W Stratton, L B Reller
Jan 1, 1978·Annals of Internal Medicine·J F DobkinN H Steigbigel
Aug 11, 1975·The Journal of Clinical Investigation·L L PelletierR G Petersdorf
Oct 17, 1974·The New England Journal of Medicine·L Weinstein, J J Schlesinger
Mar 1, 1973·The Journal of Clinical Investigation·D T Durack, R G Petersdorf
Jul 27, 1957·Journal of the American Medical Association·E W HOOKT F SELLERS
Jan 1, 1950·Transactions of the ... Meeting of the American Surgical Association·C W LILLEHEIM B VISSCHER

❮ Previous
Next ❯

Citations

Apr 16, 2003·The American Journal of the Medical Sciences·Farrin A Manian

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
J P GuggenbichlerM P Dierich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D L PatersonN Singh
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
L K Kairaitis, T Gottlieb
© 2021 Meta ULC. All rights reserved